Paulo Alexandre Cortes Salgado
AuthID: R-001-FH8
1
TITLE: Influence of HER2 expression on prognosis in metastatic triple-negative breast cancerdresults from an international, multicenter analysis coordinated by the AGMT Study Group
AUTHORS: Gampenrieder, S. P.; Dezentje, V.; Lambertini, M.; de Nonneville, A.; Marhold, M.; Le Du, F.; Salgado, A. Cortes; Costa, D. Alpuim; Batista, M. Vaz; Ruche, N. Chic; Tinchon, C.; Petzer, A.; Blondeaux, E.; Del Mastro, L.; Targato, G.; Bertucci, F.; Goncalves, A.; Viret, F.; Bartsch, R.; Mannsbart, C.; ...More
PUBLISHED: 2023, SOURCE: ESMO OPEN, VOLUME: 8, ISSUE: 1
AUTHORS: Gampenrieder, S. P.; Dezentje, V.; Lambertini, M.; de Nonneville, A.; Marhold, M.; Le Du, F.; Salgado, A. Cortes; Costa, D. Alpuim; Batista, M. Vaz; Ruche, N. Chic; Tinchon, C.; Petzer, A.; Blondeaux, E.; Del Mastro, L.; Targato, G.; Bertucci, F.; Goncalves, A.; Viret, F.; Bartsch, R.; Mannsbart, C.; ...More
PUBLISHED: 2023, SOURCE: ESMO OPEN, VOLUME: 8, ISSUE: 1
INDEXED IN: 
WOS
WOS2
TITLE: The ALMA Spectroscopic Survey in the HUDF: Nature and Physical Properties of Gas-mass Selected Galaxies Using MUSE Spectroscopy
AUTHORS: Leindert A Boogaard; Roberto Decarli; Jorge Gonzalez Lopez; Paul van der Werf; Fabian Walter; Rychard Bouwens; Manuel Aravena; Chris Carilli; Franz E Erik Bauer; Jarle Brinchmann ; Thierry Contini; Pierre Cox; Elisabete da Cunha; Emanuele Daddi; Tanio Diaz Santos; Jacqueline Hodge; Hanae Inami; Rob Ivison; Michael Maseda; Jorryt Matthee; ...More
PUBLISHED: 2019, SOURCE: ASTROPHYSICAL JOURNAL, VOLUME: 882, ISSUE: 2
AUTHORS: Leindert A Boogaard; Roberto Decarli; Jorge Gonzalez Lopez; Paul van der Werf; Fabian Walter; Rychard Bouwens; Manuel Aravena; Chris Carilli; Franz E Erik Bauer; Jarle Brinchmann ; Thierry Contini; Pierre Cox; Elisabete da Cunha; Emanuele Daddi; Tanio Diaz Santos; Jacqueline Hodge; Hanae Inami; Rob Ivison; Michael Maseda; Jorryt Matthee; ...More
PUBLISHED: 2019, SOURCE: ASTROPHYSICAL JOURNAL, VOLUME: 882, ISSUE: 2
3
TITLE: Overall survival (OS) in the IMELDA randomized phase III trial of maintenance bevacizumab (BEV) with or without capecitabine (CAP) for HER2-negative metastatic breast cancer (mBC)
AUTHORS: Joseph Gligorov; Jose Bines; Emilio Alba; Giorgio Mustacchi; Saverio Cinieri; Vineet Gupta; Jean Yves Pierga; Hakan Bozcuk; Rabab Gaafar; Sudeep Gupta; Guillermo Lopez Vivanco; Xiaojia J Wang; Romulo Costa; Kadri Altundag; Ewa Chmielowska; Sabine de Ducla; Ulrich Freudensprung; Paulo Cortes; Dinesh Doval;
PUBLISHED: 2015, SOURCE: 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium in CANCER RESEARCH, VOLUME: 75, ISSUE: 9
AUTHORS: Joseph Gligorov; Jose Bines; Emilio Alba; Giorgio Mustacchi; Saverio Cinieri; Vineet Gupta; Jean Yves Pierga; Hakan Bozcuk; Rabab Gaafar; Sudeep Gupta; Guillermo Lopez Vivanco; Xiaojia J Wang; Romulo Costa; Kadri Altundag; Ewa Chmielowska; Sabine de Ducla; Ulrich Freudensprung; Paulo Cortes; Dinesh Doval;
PUBLISHED: 2015, SOURCE: 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium in CANCER RESEARCH, VOLUME: 75, ISSUE: 9
INDEXED IN: WOS 
CrossRef
WOS CrossRef4
TITLE: Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial Full Text
AUTHORS: Joseph Gligorov; Dinesh Doval; Jose Bines; Emilio Alba; Paulo Cortes; Jean Yves Pierga; Vineet Gupta; Romulo Costa; Stefanie Srock; Sabine de Ducla; Ulrich Freudensprung; Giorgio Mustacchi;
PUBLISHED: 2014, SOURCE: LANCET ONCOLOGY, VOLUME: 15, ISSUE: 12
AUTHORS: Joseph Gligorov; Dinesh Doval; Jose Bines; Emilio Alba; Paulo Cortes; Jean Yves Pierga; Vineet Gupta; Romulo Costa; Stefanie Srock; Sabine de Ducla; Ulrich Freudensprung; Giorgio Mustacchi;
PUBLISHED: 2014, SOURCE: LANCET ONCOLOGY, VOLUME: 15, ISSUE: 12
